Viewing nowRisemec Tablet 35 mg (Risedronate Sodium 2.5 Hydrate)
Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

MFDS item code 200713911 · Notified 2007.12.31 · Insurance code 644306200
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
This medication is used to treat and prevent osteoporosis in postmenopausal women and men.
1. Adults : Administer 35 mg of risedronate sodium orally once weekly. 2. Older adults : No dosage adjustment is necessary in older adults (over 60 years of age), since the bioavailability and pharmacodynamics of this drug are similar to those in younger people. 4. Patients with renal impairment : No dosage adjustment is necessary in patients with a creatinine clearance of 30 mL/min or greater. This drug is contraindicated in patients with severe renal impairment and a creatinine clearance below 30 mL/min. ○ Food interferes with the absorption of this drug. To ensure adequate absorption, take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To help this drug reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking it with other beverages, including mineral water, may reduce absorption of this drug. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take a dose on the scheduled dosing day, take it the next morning when remembered. Take the next dose on the originally scheduled dosing day. Do not take 2 tablets on the same day.
3. Children : The safety and efficacy in children under 18 years of age have not been established.
This medication can irritate the gastric mucosa, so caution is needed for those with upper gastrointestinal diseases such as gastritis, esophageal disease, and ulcers. If symptoms such as difficulty swallowing, chest pain, or heartburn occur during use, stop taking the medication immediately and consult a physician. It is important to take it with a sufficient amount of water and to avoid lying down for at least 30 minutes after taking it. Particularly, continued use after experiencing esophageal irritation could lead to serious side effects, so care should be taken. Patients with esophageal motility disorders, hypocalcemia, severe renal impairment, pregnant or potentially pregnant women, and nursing mothers should not take this medication. Those with genetic issues such as lactose intolerance should also avoid taking it. This medication is used for the treatment of osteoporosis, and it is advisable to take it along with calcium and vitamin D. Rarely, serious side effects such as jaw osteonecrosis and atypical femur fractures have been reported with long-term use, so consult a physician immediately if unusual symptoms occur. This medication may interact with other drugs, so inform your physician of any medications currently being taken. Avoid using it during pregnancy or breastfeeding, and consult a specialist if necessary. The safety of this medication for children under the age of 18 has not been established, and it can be used by the elderly without special dosage adjustments. In case of overdose, blood calcium and phosphate levels may decrease, so visit a medical institution immediately for appropriate treatment. Store this medication out of the reach of children and do not transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent exposure to air or moisture. It should be kept at room temperature between 1 and 30 degrees Celsius.
Pale orange rectangular film-coated tablet
4 tablets/PTP (4 tablets/PTP X 1)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRisedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Austin Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Nexpam Korea Co., Ltd.

Risedronate Sodium 2.5 Hydrate 35mg
Tablet · Prescription medication
Hyutecs Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.2mg
Tablet · Prescription medication
Celix Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Myeongmun Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.